Synthesize Bio is a biotechnology company at the forefront of generative genomics, utilizing AI-driven models to simulate gene expression experiments. Their flagship product, Generate Expression Model-1 (GEM-1), is built on an extensive RNA-seq dataset and enables the generation of gene expression data from experimental designs, facilitating drug discovery and scientific research. Founded by scientists from Fred Hutchinson Cancer Center, Synthesize Bio aims to transform biopharmaceutical innovation by providing high-fidelity predictive models that enhance laboratory results and accelerate the development of new therapies.